Applications of Machine Learning and Data Mining Methods to Detect Associations of Rare and Common Variants with Complex Traits

Abstract

Machine learning methods (MLMs), designed to develop models using high-dimensional predictors, have been used to analyze genome-wide genetic and genomic data to predict risks for complex traits. We summarize the results from six contributions to our Genetic Analysis Workshop 18 working group; these investigators applied MLMs and data mining to analyses of rare and common genetic variants measured in pedigrees. To develop risk profiles, group members analyzed blood pressure traits along with single-nucleotide polymorphisms and rare variant genotypes derived from sequence and imputation analyses in large Mexican American pedigrees. Supervised MLMs included penalized regression with varying penalties, support vector machines, and permanental classification. Unsupervised MLMs included sparse principal components analysis and sparse graphical models. Entropy-based components analyses were also used to mine these data. None of the investigators fully capitalized on the genetic information provided by the complete pedigrees. Their approaches either corrected for the nonindependence of the individuals within the pedigrees or analyzed only those who were independent. Some methods allowed for covariate adjustment, whereas others did not. We evaluated these methods using a variety of metrics. Four contributors conducted primary analyses on the real data, and the other two research groups used the simulated data with and without knowledge of the underlying simulation model. One group used the answers to the simulated data to assess power and type I errors. Although the MLMs applied were substantially different, each research group concluded that MLMs have advantages over standard statistical approaches with these high-dimensional data.

Machine learning approaches for prediction of ovarian cancer driver genes from mutational and network analysis

“…The accuracy for the prediction of cancer susceptibility, survival and recurrence can be improved by applying ML methods. With the application of ML techniques, significant improvement can be observed in the accuracy of cancer prediction outcomes (Lu et al , 2014). However, appropriate validation is required for the consideration of ML methods in the routine clinical practice though they can significantly improve the understanding of disease progression (Vyas et al , 2018).…”

Comparing machine learning and logistic regression methods for predicting hypertension using a combination of gene expression and next-generation sequencing data

“…MLMs lend themselves to the genetic analysis of diseases with multiple and complex risk factors, because of the high-dimensional nature of the data. Despite some initial applications of machine learning to genetic association studies with sequence data [1, 2], MLMs remain outside of the mainstream for evaluating genotype–phenotype association.…”